| Sign In to gain access to subscriptions and/or personal tools. |
Willingness to Pay per Quality-Adjusted Life Year in a Study of Knee OsteoarthritisDepartment of Epidemiology and Public Health, University of Miami, Florida, mbyrne2{at}med.miami.edu
Pearson Educational Measurement
Houston Center for Quality of Care and Utilization Studies, Veterans Health Affairs, Houston, Texas, Department of Medicine, Baylor College of Medicine, Houston, Texas Background. Determining whether a particular medical intervention is cost-effective requires that a threshold of cost per benefit gained be established. As debate continues over the appropriate threshold, we present measures of willingness to pay (WTP) per quality-adjusted life year (QALY) for own health and 2 hypothetical osteoarthritis scenarios. Methods. One hundred ninety-three persons, located through random digit dialing in Harris County, Texas, completed face-to-face interviews collecting demographic information and health preferences using visual analog scale, time tradeoff, standard gamble, and WTP methodologies.Results. The mean WTP/QALY for all methods was lower (range, $1221-$5690/QALY) than many estimates from revealed preference studies and lower than the oft-cited arbitrary cutoff of $50 000. WTP/QALY was highest when participants were judging their personal health improvements as opposed to hypothetical scenarios. There were some significant differences in WTP/QALY across elicitation methodologies for the same scenario. Demographic characteristics were not associated with WTP/QALY measures. Conclusions. The health states and improvements in health evaluated here do not contain a risk of mortality, unlike many situations in which WTP/QALY has been previously evaluated. The lower WTP/QALY values found here may indicate that the presence of a mortality risk reduction substantially increases stated WTP/QALY. Appropriate thresholds for cost-effectiveness may be dependent on the context of a situation, including risk of mortality.
Key Words: willingness-to-pay quality-adjusted life year cost-effectiveness
Medical Decision Making, Vol. 25, No. 6,
655-666 (2005) This article has been cited by other articles:
|
|
||||||||||||||


